Syncom Formulations (India) Ltd.

View in App
8.45 -0.06 ▼-0.7%

28 September 2023, 04:01:00 PM
Volume: 566,224

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sfil.in
Market Cap 794.30 Cr.
Enterprise Value(EV) 874.49 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.22 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 38.55 Trailing Twelve Months Ending 2023-06
Industry PE 37.72 Trailing Twelve Months Ending 2023-06
Book Value / Share 2.77 Trailing Twelve Months Ending 2023-06
Price to Book Value 3.05 Calculated using Price: 8.45
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 94.00 Cr. 940,000,000 Shares
FaceValue 1
About Syncom Formulations (India) Ltd.
Syncom Formulations (India) Ltd was originally incorporated as Syncom Formulations (India) Private Limited in the state of Maharashtra on June 21, 1988 under the Companies Act, 1956. Further the status of company was changed to public limited company and thereby name of company changed to Syncom Formulations (India) Limited and a fresh certificate of change of name obtained on July 9, 1992.

Syncom Formulations (India) Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Syncom Formulations (India) Ltd. Performance

View details >>
1 Day
-0.71%
1 Week
-1.74%
1 Month
-3.54%
3 Month
+8.19%
6 Month
+56.77%
1 Year
+3.30%
2 Year
+27.07%
5 Year
+789.47%
10 Year
+105.60%

Syncom Formulations (India) Ltd. Fundamental Ratios

View details >>
7 years 2013-03 2014-03 2015-03 2016-03 2017-03 2022-03 2023-03
Return on Equity (%) 6.45 10.19 9.99 9.91 9.32 11.83 8.48
Return on Capital Employed (%) 10.00 15.29 15.55 14.72 13.28 13.72 9.68
Return on Assets (%) 4.54 6.95 6.82 6.41 5.78 8.04 5.85

Syncom Formulations (India) Ltd. Balance Sheet

View details >>
Particulars 7 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 88 95 100 109 117 222 256
Non Curr. Liab. 8 7 6 6 8 8 9
Curr. Liab. 29 42 37 66 59 78 113
Minority Int.
Equity & Liab. 124 144 143 181 184 308 378
Non Curr. Assets 63 66 59 89 97 168 196
Curr. Assets 62 78 84 92 87 140 182
Misc. Exp. not W/O
Total Assets 124 144 143 181 184 308 378

Syncom Formulations (India) Ltd. Profit and Loss

View details >>
Particulars 8 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 115 151 173 184 185 220 224 233
Other Income 1 1 2 3 3 12 15 14
Total Income 116 152 175 187 188 232 239 246
Total Expenditure -104 -135 -155 -167 -168 -200 -204 -210
PBIDT 12 17 20 19 19 32 35 36
Interest -1 0 0 0 0 -2 -3 -4
Depreciation -3 -3 -3 -3 -3 -4 -5 -5
Taxation -3 -5 -6 -6 -5 -6 -7 -7
Exceptional Items -1 0 0 0 0 0
PAT 6 9 10 10 11 20 20 21
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 6 9 10 10 11 20 20 21
Adjusted EPS 0 0 0 0 0 0 0 0

Syncom Formulations (India) Ltd. Cash Flow

View details >>
Particulars 7 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 6 7 0 24 14 16 11
Cash Fr. Inv. 0 -4 1 -23 -18 -27 -45
Cash Fr. Finan. -6 -1 1 -2 5 8 35
Net Change -1 2 2 -1 1 -2 1
Cash & Cash Eqvt 4 5 7 6 7 0 1

Syncom Formulations (India) Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 41.18 44.01 44.01 46.12 50.57 50.57 50.57 50.57 50.57
Public 58.82 55.99 55.99 53.88 49.43 49.43 49.43 49.43 49.43
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Syncom Formulations (India) Ltd. Announcements

View details >>
Thu, 28 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of the 35th Annual General Meeting
Thu, 28 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of voting results in compliance with regulation 44(3) in relation to 35th Annual general Meeting of the company
Wed, 27 Sep 2023
Closure of Trading Window
The window for trading in the Shares of the Company shall remain closed from 1st Oct 2023 till completion of 48 hrs after the declaration of unaudited standalone and consolidated financial results for the quater and half year ended on 30th September 2023

Syncom Formulations (India) Ltd. Technical Scans

View details >>
Wed, 27 Sep 2023
High Increase in 6 Months High Increase in 6 Months
High Increase in 5 Years High Increase in 5 Years
CCI Bullish CCI Bullish
William %R Trending Up William %R Trending Up
Tue, 26 Sep 2023
Closing Below Previous Low Closing Below Previous Low

Syncom Formulations (India) Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,548.18 1,137.55 -0.2%
Divi's Laboratories Ltd. 99,978.12 3,663.85 -2.7%
Cipla Ltd. 95,303.83 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. 91,645.73 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. 73,382.66 5,026.15 -1.5%
Mankind Pharma Ltd. 70,333.32 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. 62,570.10 1,858.55 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.45 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-06 67.67 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-06 30.63 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.40 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 109.79 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 54.96 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.73 1,858.55 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-06 7.62 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-06 3.92 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.73 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.70 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.75 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.53 1,858.55 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,858.55 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,858.55 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,858.55 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,858.55 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,858.55 +0.5%

Syncom Formulations (India) Ltd. FAQ's

What is Syncom Formulations share price?
Can I buy Syncom Formulations shares now?
What is the Market Cap of Syncom Formulations?
What are the key metrics to analyse Syncom Formulations?
What is the 52 Week High and Low of Syncom Formulations?
What is the trend of Syncom Formulations share price?